Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | ||||
| Net Income | 9,990 | -22,050 | -16,490 | -10,650 |
| Depreciation Amortization | 430 | 1,590 | 1,210 | 790 |
| Other Working Capital | -18,020 | -11,150 | -1,770 | -3,860 |
| Other Operating Activity | 980 | 2,430 | -5,850 | 510 |
| Operating Cash Flow | $-6,620 | $-29,180 | $-22,900 | $-13,210 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -60 | -800 | -560 | -450 |
| Other Investing Activity | -10 | 240 | -50 | -50 |
| Investing Cash Flow | $-70 | $-560 | $-610 | $-500 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 90 | 84,840 | 84,380 | 700 |
| Financing Cash Flow | $90 | $84,840 | $84,380 | $700 |
| Exchange Rate Effect | 10 | 10 | 30 | -30 |
| Beginning Cash Position | 112,690 | 54,110 | 53,960 | 53,190 |
| End Cash Position | 106,100 | 109,220 | 114,870 | 40,160 |
| Net Cash Flow | $-6,590 | $55,110 | $60,900 | $-13,030 |
| Free Cash Flow | ||||
| Operating Cash Flow | -6,620 | -29,180 | -22,900 | -13,210 |
| Free Cash Flow | -6,620 | -29,180 | -22,900 | -13,210 |